Volume 28, Number 4—April 2022
CME ACTIVITY - Research
Unique Clinical, Immune, and Genetic Signature in Patients with Borrelial Meningoradiculoneuritis1
Figure 4
![Correlation between the levels of 5 inflammatory mediators in CSF and CSF leukocyte counts among 120 patients with Lyme neuroborreliosis treated in Ljubljana, Slovenia, during 2006–2013. A) CXCL9; B) CXCL10; C) IL-17; D) CXCL12; E) CXCL13. Solid lines inside the graph represent linear regression; dotted lines indicate 95% CIs. ρ and p values were derived using the Spearman correlation. CSF, cerebrospinal fluid.](/eid/images/21-1831-F4.jpg)
Figure 4. Correlation between the levels of 5 inflammatory mediators in CSF and CSF leukocyte counts among 120 patients with Lyme neuroborreliosis treated in Ljubljana, Slovenia, during 2006–2013. A) CXCL9; B) CXCL10; C) IL-17; D) CXCL12; E) CXCL13. Solid lines inside the graph represent linear regression; dotted lines indicate 95% CIs. ρ and p values were derived using the Spearman correlation. CSF, cerebrospinal fluid.
1Part of the research reported here was presented at the 31st European Congress of Clinical Microbiology & Infectious Diseases (online), July 9–12, 2021.
2These first authors contributed equally to this article.
3These senior authors contributed equally to this article.
Page created: February 22, 2022
Page updated: March 22, 2022
Page reviewed: March 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.